APGE position history
The shares of Apogee Therapeutics (APGE) that Opaleye Management Inc. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q3: 363,257 shares, $14M, 2.0% of portfolio, New
- 2025 Q4: 776,514 shares, $59M, 7.7% of portfolio, Add +113.8%
- 2026 Q1: 390,000 shares, $33M, 4.3% of portfolio, Reduce −49.8%
- 2026 Q2: 390,000 shares, $52M, 4.7% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|